Apollo ties up with ConnectedLife
Apollo Hospitals has integrated its Artificial Intelligence-powered Cardiovascular Disease Risk (AICVD) tool with ConnectedLife’s digital solutions for wellness, condition management and other health-focused applications.
image for illustrative purpose
Hyderabad: Apollo Hospitals has integrated its Artificial Intelligence-powered Cardiovascular Disease Risk (AICVD) tool with ConnectedLife's digital solutions for wellness, condition management and other health-focused applications. The AICVD tool can predict the risk of cardiovascular disease. This will empower healthcare providers with the tools to predict the risk of cardiac disease and initiate intervention early.
Dr Prathap C Reddy, Chairman, Apollo Hospitals Group said, "The rising burden of NCDs led by cardiovascular diseases is a problem that is increasing as our population ages. The collaboration with ConnectedLife brings together our experience and expertise in developing predictive AI tools with their healthcare solutions to give a comprehensive tool to predict risk and deliver best clinical results."
The clinical integration was demonstrated during the online event to announce the collaboration. The cardiac risk scoring tool is remarkable for its speed in processing data and accuracy in predicting the probability of a patient developing coronary disease. Using the tool, physicians are enabled to deliver proactive, pre-emptive and preventive care for at-risk individuals.
